The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...

Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise ...

Phoenix Asia Holdings faces significant risks, including regulatory risks, customer concentration and uncertainties in the ...

EcoCeres Inc., a producer of sustainable fuel backed by Bain Capital, is exploring an initial public offering that could ...

A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.

Smithfield Foods on Tuesday unveiled terms for its planned initial public offering, with the largest U.S. pork producer ...

(Reuters) - Smithfield Foods is targeting a valuation of up to $10.73 billion in its U.S. initial public offering, the ...

Chinese biotech Ascentage Pharma has taken the first US biotech initial public offering (IPO) of 2025 over the finish line, ...

Smithfield Foods is targeting a valuation of up to $10.73 billion in its U.S. initial public offering, the Farmland bacon ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...